ACA

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 632 M736.9 M797.8 M801.1 M571.7 M 2.91 B Gross profit 125.4 M166.1 M191.9 M181.3 M120.9 M 660.2 M Operating expenses 69.6 M5 M84.2 M104.7 M73.8 M 267.7 M Selling/general/admin expenses 73.7 M73 M82.2 M80.9 M75.8 M 311.9 M Research & development ————— — Operating income 55.8 M94.8 M112.3 M93.8 M47.1 M 348 M Non-Operating Income, Total 1.6 M4.4 M200 K-2.4 M-100 K 2.1 M Interest expense, net of interest capitalized 28.3 M28.5 M27.1 M—24 M — Non-Operating Income, excl. Interest Expenses -28.4 M-26.3 M-27 M-1.8 M-24 M -79.1 M Unusual income/expense 1.7 M2.2 M100 K-600 K-100 K 1.6 M Pretax income 29.2 M69.8 M87.1 M70 M24.6 M 251.5 M Equity in earnings ————— — Taxes 5.6 M10.1 M14.1 M5.9 M1.3 M 31.4 M Non-controlling/minority interest ————— — After tax other income/expense -400 K-3.4 M2.1 M-9.7 M-3 M -14 M Net income before discontinued operations 23.6 M59.7 M73 M52.1 M23.3 M 208.1 M Discontinued operations ————14.5 M — Net income 23.6 M59.7 M73 M52.1 M37.8 M 222.6 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 23.5 M59.6 M72.9 M52 M37.7 M 222.2 M Basic earnings per share (Basic EPS) 0.481.221.491.060.77 4.54 Diluted earnings per share (Diluted EPS) 0.481.221.481.060.77 4.53 Average basic shares outstanding 48.7 M48.9 M49 M48.9 M49 M — Diluted shares outstanding 49.2 M49 M49.1 M49 M49.2 M — EBITDA 109.4 M217.2 M163.9 M118.1 M100.6 M 599.8 M EBIT 55.8 M161.1 M107.7 M143.5 M47.1 M 459.4 M Cost of revenue 506.6 M570.8 M605.9 M619.8 M450.8 M 2.25 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 53.6 M56.1 M56.2 M59 M53.5 M 224.8 M